Position in BMY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$4,480,876
-$235,631 QoQ
Shares Held
77,766
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#576
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 4%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Smithfield Trust Co holds $61,006,231 across 17 Drug Manufacturers - General names. BMY ranks #5 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
79,661 | $20,231,503 | |
| 2 | MRK |
Merck & Co., Inc.
|
92,939 | $11,942,661 | |
| 3 | LLY |
ELI LILLY & Co
|
9,506 | $11,401,781 | |
| 4 | ABBV |
AbbVie Inc.
|
31,546 | $7,938,235 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
77,766 | $4,480,876 | |
| 6 | AMGN |
Amgen Inc
|
6,994 | $2,532,667 | |
| 7 | PFE |
Pfizer Inc
|
66,244 | $1,595,154 | |
| 8 | AZN |
Astrazeneca PLC
|
2,117 | $401,425 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,480,876 | 77,766 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $4,716,507 | 77,766 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $988,126 | 18,319 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $698,057 | 15,478 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $739,528 | 15,976 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $998,771 | 16,376 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $974,132 | 17,223 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $891,117 | 17,223 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $706,216 | 17,005 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,084,490 | 19,998 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,079,920 | 21,047 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $1,295,336 | 22,318 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $1,441,304 | 22,538 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $1,576,455 | 22,745 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,672,045 | 23,239 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,656,894 | 23,307 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,546,468 | 20,084 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,376,469 | 18,848 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,153,037 | 18,493 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,094,289 | 18,494 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,365,065 | 20,429 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,317,459 | 20,869 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,305,110 | 21,040 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,313,779 | 21,791 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,319,706 | 22,444 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,125,557 | 20,193 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||